Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders. Xu Q, Zhang L, Duan X, Zhou K, Li Z, Yang X, Wang J, Jiang J, Xu K, Yu G, et al. Neurol Neuroimmunol Neuroinflamm. 2026 Jul; 13(4):e200586. PMID: 42044464. Abstract CommentRecommendBookmarkWatch
